IFNG and neoplasm: Type 1 immune response is a key component of cell-mediated anticancer immunity and is characterized by tumor-induced IFN-γ-producing Th1 cells, NK cells, NKT cells, cytotoxic T lymphocytes, and γδ T cells (75).